Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.12%) to 9216.67, DAX (0.15%) to 23639.41, CAC40 (0.01%) to 7853.59, STOXX 600 (0.16%) to 554.12

Sep 19 ,2025

  • Synopsis:

    • European equity markets ended mixed to lower, with the Stoxx Europe 600 range-bound trading in a narrow range either side of unchanged on the day. Italy +0.7%, Switzerland +0.6% and Finland +0.5% led the outperformers, while Portugal (0.5%), Finland (0.4%) and the Netherlands (0.3%) joined France, Germany and the FTSE 100 among the underperformers.

    • In geopolitical developments, Presidents Trump and Xi to speak Friday following talks in Madrid that appeared to produce agreement on TikTok. Technology may feature in talks after Beijing ramped up scrutiny on Nvidia this week. Trump sounded positive ahead of the call, saying two sides close to a deal and flagged another extension of tariff deadline beyond November. Recent press reports have also mentioned possibility of new China purchase commitments involving soybeans and Boeing (BA) aircraft.

    • In other news, EU is planning to phase out bloc's use of Russian LNG at quicker pace after pressure from Trump. In politics, French PM Lecornu has begun a second phase of consultations with party leaders after first round of talks with political leaders, trade unions and business groups. Lecornu has not yet revealed his initial proposals, according to allies.

    • On the macro data front, UK retail sales a bit firmer than expected but GfK consumer confidence measure dipped amid worries over tax policy and inflation. UK government borrowing higher than expected ahead of November budget. Drop in German producer prices was larger than forecast. Also, latest French business climate index held steady despite uncertain political backdrop. Business confidence reading remained at 96 in September versus 95 forecast. Was the fourth consecutive month sentiment has held around the 96 level, yet below the long-term average of 100. Insee highlighted that business climate has improved in services and wholesale trade, stable in construction and weakened in manufacturing and retail trade.

    • In corporate news, Stabilus (STM.GR) is trading lower on the back of company's updated FY25 guidance after announcing it will adopt a transformation program to strengthen its long-term competitiveness. Stroeer SE & Co. (SAX.GR) also adjusted its outlook for FY25 downward. In the UK, Close Brothers Group (CBG.LN) postponed the publication of 2025 preliminary results by one week to 30-Sep. In management changes, BHP Group (BHP.LN) likely to appoint Geraldine Slattery as Mike Henry successor, FT reported.

    • In M&A, Spire Healthcare Group (SPI.LN) confirmed that it has commenced process to hold discussions with number of parties in relation to a range of options including potential sale. Credit Agricole (ACA.FP) has been reportedly working with Deutsche Bank and Rothschild to explore options on Banco BPM (BAMI.IM). Meanwhile, Scout24 (G24.GR) acquired Spanish online real estate platforms Fotocasa and Habitaclia. Also, EQT AB (EQT.SS) is seeking to sell GlobalConnect, according to the FT. Of note, shares in Dassault (AM.FP) are trading lower after a Poltico article flagged that Berlin is weighing to bring Sweden and UK into the €100B project as tensions simmer

    • The week ahead sees SNB and Riksbank interest rate decisions, Eurozone, France, Germany, UK Sep preliminary manufacturing/services PMIs, Germany Sep Ifo survey as well as earnings/updates from H&M Hennes & Mauritz (HM.B.SS), Kingfisher (KGF.LN), JD Sports Fashion (JD.LN), MFE-MEDIAFOREUROPE (MFEB.IM), Smiths Group (SMIN.LN) and TUI Group (TUI1.GR).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Banks +0.54%, Basic Resources +0.48%, Utilities +0.26%, Health Care +0.26%, Food & Beverage +0.13%, Insurance +0.10%, Chemicals (0.04%), Autos & Parts (0.10%), Travel & Leisure (0.16%), Telecom (0.16%)

      • Underperformers

        • Media (2.75%), Persnl & HHold Goods (1.01%), Financial Svcs (0.83%), Technology (0.82%), Oil & Gas (0.77%), Retail (0.67%), Construct & Mtls (0.27%), Ind Goods & Svcs (0.25%), Real Estate(0.18%)

    • Macro/Peripheral markets:

      • Geopolitics:

        • Trump ties new Russia sanctions to Europe's end of oil imports (Bloomberg)

        • Trump and Starmer renew 'special relationship' with £150bn US investment pledge (Reuters)

        • EU accelerates Russian LNG phaseout amid Trump pressure for tougher energy curbs (Bloomberg)

        • Estonian airspace violated by Russian jets on Friday, sources say (Reuters)

      • EU

        • Digital euro debate rolls on as finance ministers mull stablecoin rules (FT)

      • UK:

        • British consumer confidence dips amid economic slowdown fears (link)

        • Reeves risks £18bn shortfall if UK productivity gains falter, IFS warns (FT)

        • UK households shatter Isa records with £103bn cash savings surge (FT)

      • Germany

        • Germany explores how to replace France in Europe's flagship fighter jet project (Politico)

      • Switzerland

        • SNB set to hold rates steady as inflation eases cut pressure (Bloomberg)

      • Sweden

        • Swedish central bank seen on hold next week, but rate cut not ruled out, Reuters poll shows (Reuters)

    • Company news:

      • Notable Gainers

        • +17.2% AKW.FP (Akwel €9.52, +1.40) -- H1 earnings

        • +14.3% PRTC.LN (PureTech Health £1.22, +0.15) -- Tang Capital Management LLC announces 3.07% stake in PureTech Health PLC - filing

        • +13.9% SPI.LN (Spire Healthcare Group £2.47, +0.30) -- responds to speculation; confirms it has commenced process to hold discussions with number of parties in relation to a range of options including potential sale

        • +9.4% NXI.FP (Nexity €10.95, +0.94) -- Oddo upgrade

        • +9.3% TIMA.GR (ZEAL Network €49.40, +4.20) -- raises FY guidance

        • +5.6% EMG.LN (Man Group £1.76, +0.09) -- UBS upgrade

        • +5.6% PHARM.NA (Pharming Group €1.25, +0.07) -- sector move

        • +4.0% IDIA.SW (Idorsia CHF4.02, +0.15) -- receives approval from Swissmedic for JERAYGO

        • +3.3% BFSA.GR (Befesa €27.96, +0.90) -- initiated buy at UBS

        • +2.6% VLA.FP (Valneva €4.38, +0.11)

        • +2.1% GLEN.LN (Glencore £3.14, +0.07) -- Glencore reportedly weighing sale of its Kamoto copper mine in Congo -- Bloomberg

        • +1.8% AVTX.NA (Avantium €7.53, +0.13)

        • +1.4% ACA.FP (Credit Agricole €16.53, +0.23) -- Credit Agricole has been working with Deutsche Bank and Rothschild to explore options on Banco BPM -- Bloomberg, citing sources

        • +1.1% STLAM.IM (Stellantis €8.50, +0.09) -- Berenberg upgrade

        • +1.1% IPN.FP (Ipsen €115.50, +1.30) -- Ipsen's Bylvay (odevixibat) approved in Japan for rare liver disease PFIC

        • +0.7% ONCO.SS (Oncopeptides SEK4.79, +0.04) -- sector move

        • +0.3% ABVX.FP (Abivax €70.10, +0.20) -- sector move

        • +0.1% DBV.FP (DBV Technologies €1.63, -0.00) -- FDA panel to meet 9-Oct to discuss topics including influenza strains and allergen standardization

      • Notable Decliners

        • -34.8% FUM.LN (Futura Medical £0.06, -0.03) -- FY trading update

        • -20.6% THRU.LN (Thruvision Group £0.01, -0.00) -- FY earnings

        • -9.6% S30.FP (Solutions 30 €1.04, -0.11) -- BNP Paribas Exane downgrade

        • -8.6% KNIN.SW (Kuehne & Nagel CHF154.90, -14.60) -- Deutsche Bank downgrade

        • -6.6% SIGN.SW (SIG Combibloc Group CHF8.88, -0.63) -- Morgan Stanley downgrade

        • -5.7% LSEG.LN (London Stock Exchange Group £81.46, -4.94)

        • -5.7% AM.FP (Dassault Aviation €276.40, -16.80) -- Berlin is weighing bringing Sweden and UK into the €100B project as tensions simmer with France's Dassault -- Politico; initiated sell at Goldman Sachs

        • -5.2% G24.GR (Scout24 €103.10, -5.70) -- acquires Spanish online real estate platforms Fotocasa and Habitaclia

        • -3.7% ELK.NO (Elkem NOK25.82, -0.98)

        • -3.7% ILM1.GR (Medios €14.02, -0.54)

        • -2.8% STAB1L.GR (Stabilus €24.25, -0.70) -- updates FY guidance

        • -2.5% HO.FP (Thales €246.50, -6.30) -- initiated sell at Goldman Sachs

        • -2.3% CBG.LN (Close Brothers Group £4.86, -0.11) -- postpones publication of 2025 preliminary results by one week to 30-Sep-25

        • -2.2% EMBRAC.B.SS (Embracer Group SEK98.04, -2.24) -- ABG Sundal Collier downgrade

        • -2.1% AHT.LN (Ashtead Group £52.52, -1.12) -- RBC Capital Markets downgrade

        • -2.0% TFBANK.SS (TF Bank SEK170.50, -3.52) -- to change corporate name to Avarda Bank AB

    • EU companies reporting Monday:

      • France: GENFIT (GNFT.FP), Aelis Farma (AELIS.FP)

      • UK: Elixirr International (ELIX.LN), Wilmington (WIL.LN), Creo Medical Group (CREO.LN)

  • Data:

    • Economics:

      • UK Aug Retail Sales +0.7% y/y vs consensus +0.6% and prior revised +0.8% from +1.1%

      • Germany Aug PPI (2.2%) y/y vs consensus (1.8%) and prior (1.5%)

      • France Sep Business Survey 96 vs consensus 96 and prior revised 97 from 96

    • Markets:

      • WTI Crude (Oct 25): ($0.64) or (1.01%) to $62.93

      • €-$ (0.0049) or (0.41%) to 1.1740

      • £-$ (0.0083) or (0.61%) to 1.3472

      • €-£ +0.0018 to 0.8714

      • S&P 500 +0.04%

        • Performance year-to-date

        • FTSE 100: +12.77%

        • DAX: +18.74%

        • CAC: +6.41%

        • MIB: +23.92% Stoxx 600: +9.16%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE